ResMed [RMD] vs Intuitive Surgical [ISRG] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: ResMed wins in 15 metrics, Intuitive Surgical wins in 4 metrics, with 0 ties. ResMed appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricResMedIntuitive SurgicalBetter
P/E Ratio (TTM)29.2663.00ResMed
Price-to-Book Ratio6.839.08ResMed
Debt-to-Equity Ratio14.270.00Intuitive Surgical
PEG Ratio0.972.59ResMed
EV/EBITDA21.7349.26ResMed
Profit Margin (TTM)27.22%28.51%Intuitive Surgical
Operating Margin (TTM)33.87%30.47%ResMed
EBITDA Margin (TTM)33.87%30.47%ResMed
Return on Equity25.86%16.04%ResMed
Return on Assets (TTM)14.02%9.02%ResMed
Free Cash Flow (TTM)$1.65B$1.30BResMed
Dividend Yield0.63%N/AN/A
1-Year Return16.99%-7.24%ResMed
Price-to-Sales Ratio (TTM)7.9317.73ResMed
Enterprise Value$40.43B$156.94BIntuitive Surgical
EV/Revenue Ratio7.8617.16ResMed
Gross Profit Margin (TTM)60.84%66.31%Intuitive Surgical
Revenue per Share (TTM)$35$26ResMed
Earnings per Share (Diluted)$9.52$7.18ResMed
Beta (Stock Volatility)0.831.61ResMed
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

ResMed vs Intuitive Surgical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
ResMed1.00%3.81%0.69%9.74%32.10%23.15%
Intuitive Surgical-0.59%2.38%-4.32%-15.90%-3.00%-14.19%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
ResMed16.99%32.88%55.64%398.02%790.72%1,394.32%
Intuitive Surgical-7.24%145.65%79.24%765.95%1,346.41%5,952.36%

News Based Sentiment: ResMed vs Intuitive Surgical

ResMed

News based Sentiment: MIXED

October was a mixed month for ResMed, with positive insider activity and a new product launch offset by a significant trade investigation. While the insider transactions suggest confidence, the Commerce Department probe introduces substantial uncertainty, making it a moderately important month for investors.

View ResMed News Sentiment Analysis

Intuitive Surgical

News based Sentiment: POSITIVE

Intuitive Surgical demonstrated strong financial performance in Q2 2025, coupled with significant product innovation and regulatory approvals. While analyst price targets were mixed, the overall sentiment remains positive, supported by a 'Moderate Buy' consensus and increased institutional holdings, suggesting continued growth potential.

View Intuitive Surgical News Sentiment Analysis

Performance & Financial Health Analysis: ResMed vs Intuitive Surgical

MetricRMDISRG
Market Information
Market Cap i$40.79B$163.30B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i873,9602,417,000
90 Day Avg. Volume i959,8802,455,233
Last Close$281.38$449.69
52 Week Range$199.92 - $293.81$425.00 - $616.00
% from 52W High-4.23%-27.00%
All-Time High$301.34 (Sep 06, 2021)$616.00 (Jan 20, 2025)
% from All-Time High-6.62%-27.00%
Growth Metrics
Quarterly Revenue Growth0.10%0.21%
Quarterly Earnings Growth0.30%0.25%
Financial Health
Profit Margin (TTM) i0.27%0.29%
Operating Margin (TTM) i0.34%0.30%
Return on Equity (TTM) i0.26%0.16%
Debt to Equity (MRQ) i14.270.00
Cash & Liquidity
Book Value per Share (MRQ)$40.77$49.79
Cash per Share (MRQ)$8.26$14.86
Operating Cash Flow (TTM) i$1.75B$2.83B
Levered Free Cash Flow (TTM) i$1.21B$1.82B
Dividends
Last 12-Month Dividend Yield i0.63%N/A
Last 12-Month Dividend i$1.59N/A

Valuation & Enterprise Metrics Analysis: ResMed vs Intuitive Surgical

MetricRMDISRG
Price Ratios
P/E Ratio (TTM) i29.2663.00
Forward P/E i27.0757.55
PEG Ratio i0.972.59
Price to Sales (TTM) i7.9317.73
Price to Book (MRQ) i6.839.08
Market Capitalization
Market Capitalization i$40.79B$163.30B
Enterprise Value i$40.43B$156.94B
Enterprise Value Metrics
Enterprise to Revenue i7.8617.16
Enterprise to EBITDA i21.7349.26
Risk & Other Metrics
Beta i0.831.61
Book Value per Share (MRQ) i$40.77$49.79

Financial Statements Comparison: ResMed vs Intuitive Surgical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)RMDISRG
Revenue/Sales i$1.35B$2.44B
Cost of Goods Sold i$527.93M$822.10M
Gross Profit i$820.07M$1.62B
Research & Development i$86.44M$313.30M
Operating Income (EBIT) i$456.57M$743.40M
EBITDA i$532.89M$898.70M
Pre-Tax Income i$458.05M$832.10M
Income Tax i$78.35M$167.90M
Net Income (Profit) i$379.71M$664.20M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)RMDISRG
Cash & Equivalents i$1.21B$2.57B
Total Current Assets i$3.51B$7.66B
Total Current Liabilities i$1.02B$1.54B
Long-Term Debt i$811.41MN/A
Total Shareholders Equity i$5.97B$17.21B
Retained Earnings i$6.08B$7.14B
Property, Plant & Equipment i$288.62MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)RMDISRG
Operating Cash Flow i$441.40M$833.10M
Capital Expenditures i$-30.59M$-116.60M
Free Cash Flow i$504.99M$465.00M
Debt Repayment i$-5.00MN/A
Common Stock Repurchase i$-100.01MN/A

Short Interest & Institutional Ownership Analysis

MetricRMDISRG
Shares Short i8.65M5.72M
Short Ratio i8.772.50
Short % of Float i0.07%0.02%
Average Daily Volume (10 Day) i873,9602,417,000
Average Daily Volume (90 Day) i959,8802,455,233
Shares Outstanding i146.39M356.60M
Float Shares i145.48M356.30M
% Held by Insiders i0.01%0.01%
% Held by Institutions i0.65%0.89%

Dividend Analysis & Yield Comparison: ResMed vs Intuitive Surgical

MetricRMDISRG
Last 12-Month Dividend i$1.59N/A
Last 12-Month Dividend Yield i0.63%N/A
3-Year Avg Annual Dividend i$1.60N/A
3-Year Avg Dividend Yield i0.23%N/A
3-Year Total Dividends i$4.79N/A
Ex-Dividend DateFeb 13, 2025N/A